Sponsor Pipeline

Swiss Cancer Institute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
18
Active Trials
8
Recruiting
2
Phase 3
10
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07617610 Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic… Recruiting
2026-05-18 NCT07593482 Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
1
Phase 2/3
1
Phase 2
12
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07574047 MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced… Melanoma Not Yet Recruiting
Phase 3
NCT02051218 Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks… Metastatic Breast Cancer Active, Not Recruiting
Phase 2/3
NCT07149649 Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC) Metastatic NSCLC - Non-Small Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT06452394 NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline Breast Cancer Recruiting
NCT06835049 Feasibility of Total Neoadjuvant Treatment With HYPErthermia in Patients With High-risk… Sarcoma,Soft Tissue Recruiting
NCT06401980 Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Metastatic Castration-resistant Prostate Cancer Recruiting
NCT06358573 Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early… Triple-negative Breast Cancer Recruiting
NCT07365423 Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) Recurrent Prostate Cancer Recruiting
NCT07020065 Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in… Metastatic NSCLC - Non-Small Cell Lung Cancer Recruiting
NCT04604067 Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter… Diffuse Large B-cell Lymphoma Active, Not Recruiting
NCT03937843 Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma Seminoma Active, Not Recruiting
NCT04630730 Intravesical Recombinant BCG Followed by Perioperative Chemo-immunotherapy for Patients… Bladder Cancer Active, Not Recruiting
NCT04245514 Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer Active, Not Recruiting
NCT07158489 Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced… NSCLC Not Yet Recruiting
NCT07593482 Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen… B-cell Lymphoma Not Yet Recruiting
Not specified
NCT06114108 Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV… Non-small Cell Lung Cancer (NSCLC) Recruiting
NCT07617610 Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic… Metastatic Colorectal Cancer Recruiting
NCT06090162 LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell… Non-hodgkin Lymphoma, B Cell Active, Not Recruiting
Disease Areas
Get alerts when Swiss Cancer Institute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free